Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01879215
Other study ID # 817841
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date June 2013
Est. completion date July 2020

Study information

Verified date July 2020
Source University of Pennsylvania
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

This study will utilize T1-Rho MRI to evaluate the effect of intramedullary nailing on patellofemoral articular cartilage when the surgery is performed using the infrapatellar vs. the suprapatellar approach. Subjects will be randomized to one or the other standard care surgical approaches.


Recruitment information / eligibility

Status Completed
Enrollment 30
Est. completion date July 2020
Est. primary completion date March 2020
Accepts healthy volunteers No
Gender All
Age group 21 Years to 50 Years
Eligibility Inclusion Criteria:

1. Isolated tibial shaft fractures indicated for intramedullary nailing,

2. Acute tibia fractures,

3. Closed or open tibia fractures,

4. Skeletally mature patient between the ages of 21 and 50,

5. No prior history of knee surgery,

6. No prior history of knee pain,

7. No history of degenerative joint disease or inflammatory arthropathy

8. Not pregnant or known to be under the jurisdiction of the Department of Corrections

9. Able to provide informed consent.

10. Qualifies for standard care tibial IM nailing using either a suprapatellar or infrapatellar approach with no physician preference or definitive clinical indication for one or the other approach

11. Ability to communicate, read, and write in English

12. Intent of subject to receive follow up fracture care at the PI's institution.

Exclusion Criteria:

1. Tibial fractures requiring articular reconstruction (tibial plateau fractures and pilon fractures),

2. Periprosthetic fractures,

3. Nonunions or malunions,

4. History of previous knee surgery,

5. History of preexisting knee pain,

6. History of degenerative arthritis or inflammatory arthropathy, any evidence of degenerative changes of pre-operative knee radiographs, and any concomitant injury to that limb.

7. Any contraindication to MRI imaging

8. Retained stainless steel hardware proximal to the knee joint including, but not limited to prior knee replacement.

9. Under age 18 at the time of presentation, pregnant or planning to become pregnant within the study period, or under the jurisdiction of the Department of Corrections.

10. Inability to provide informed consent

11. Participation in any other medical device or medicinal product study within the previous month that could influence the results of the present study

12. Insurance or other circumstantial restriction that would prohibit or interfere with the subject's ability to receive follow up care at the PI's institution.

13. Any condition, acute or chronic, that in the opinion of the attending physician or the Principal Investigator, would contraindicate participation in this study.

Study Design


Related Conditions & MeSH terms


Intervention

Procedure:
Intramedullary nailing of the tibia
Standard care surgery

Locations

Country Name City State
United States Hospital of the University of Pennsylvania Philadelphia Pennsylvania

Sponsors (2)

Lead Sponsor Collaborator
University of Pennsylvania Synthes USA HQ, Inc.

Country where clinical trial is conducted

United States, 

Outcome

Type Measure Description Time frame Safety issue
Primary T1Rho MRI to quantify patellofemoral cartilage changes after IM nailing of the tibia as a primary treatment for acute tibial fractures. The difference in proteoglycan content of patellofemoral articular cartilage as quantified using spin lattice relaxation in a rotating frame (T1? MRI weighted image) at 6 months post-hospital discharge between two groups randomized to undergo either a suprapatellar or infrapatellar approach to tibial IM nailing. Up to 6 months post-discharge
Secondary SF-36 The difference in quality of life outcomes (Medical Outcomes Study: 36-Item Short Form Survey) at 6 months post-hospital discharge between two groups randomized to undergo either a suprapatellar or infrapatellar approach to tibial IM nailing. Pre-op, 2 week scan, 6 months post discharge
Secondary SMFA MFA46A Injury and Arthritis Survey Pre-op, 2 week scan, 6 months post discharge